Outcome of Patients Treated With IABP

Nanjing Medical University1,000 enrolled

Overview

Intra-Aortic Balloon Pumps (IABP) is a widely used and effective left ventricular adjuvant therapy. IABP is an inflatable device placed in the aorta that inflates with diastole and deflates with systole. The aim of this study is to investigate the outcome of patients treated With IABP, and to evaluate the short-term and long-term outcomes of patients with IABP.

Study Type

OBSERVATIONAL

Enrollment

1,000

Conditions

Acute Coronary Syndrome Cardiogenic Shock Coronary Artery Disease Heart Failure Left Ventricular Dysfunction Low Cardiac Output Syndrome Post-cardiac Surgery

Interventions

Intra Aortic Balloon PumpDEVICE

Intra Aortic Balloon Pump (IABP) is a circulatory mechanical support device, placed in descending aorta, distally from left subclavian artery and proximally from renal artery. IABP works with counterpulsation concept, synchronized with heart cycle.

Eligibility

Sex: ALLMin age: 1 YearMax age: 100 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients receiving IABP for circulatory support Exclusion Criteria: * Refusal of consent

Locations (1)

The first affiliated hospital of nanjing medical university

Nanjing, Jiangsu, China

RECRUITING

Outcomes

Primary Outcomes

All-cause mortality

Time frame: 30 days after IABP implantation

Secondary Outcomes

All-cause mortality

Time frame: 3 months after IABP implantation

Central Contacts

Hong Liu, MD

CONTACT

18801281613 DR.HONGLIU@FOXMAIL.COM

Yong-feng Shao, MD

CONTACT

02568303100 yfshaojph@sina.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.